# Changes in Gingival Crevicular Fluid Endocan (ESM-1) Levels as a Potential Biomarker After Non-Surgical Periodontal Treatment in Periodontitis Patients

**Authors:** Bilge Karci, Kevser Sokmen

PMC · DOI: 10.3390/biomedicines13051159 · Biomedicines · 2025-05-09

## TL;DR

This study explores whether changes in a protein called endocan in the gums can indicate periodontal disease and how it responds to treatment.

## Contribution

The study evaluates endocan (ESM-1) as a potential biomarker for periodontitis and its response to non-surgical treatment.

## Key findings

- Periodontitis patients had higher ESM-1 levels than controls, which decreased significantly after treatment.
- TNF-α levels were significantly higher in periodontitis patients and decreased after treatment.
- ESM-1 correlated with VEGF-A and TNF-α, suggesting a possible role in disease monitoring.

## Abstract

Background: This study aimed to investigate endocan (ESM-1) levels in periodontitis patients before and after non-surgical periodontal treatment by analyzing the relationship between vascular endothelial growth factor A (VEGF-A) and tumor necrosis factor-alpha (TNF-α) in gingival crevicular fluid (GCF). Methods: This study included 26 periodontally healthy people as controls (Group 1) and 27 patients with Stage III-Grade B periodontitis (Group 2). Demographic and periodontal variables were assessed. GCF samples were collected from every subject both before and 6 weeks following non-surgical periodontal therapy (NSPT). Using an enzyme-linked immunosorbent test, biomarker levels were determined. Results: The periodontitis patients showed higher ESM-1 levels than the controls, although the difference was not significant (p > 0.005). The ESM-1 levels decreased significantly after treatment (p = 0.001). The VEGF-A levels did not differ significantly between the periodontitis patients and controls (p > 0.005) and decreased non-significantly following treatment (p > 0.005). The TNF-α levels were significantly higher in the periodontitis patients than the controls (p = 0.000) and decreased significantly after treatment (p = 0.000). A significant correlation was found between TNF-α and both probing depth (PD) and interproximal clinical attachment level (iCAL) in the control group (p < 0.05). In the periodontitis group, the VEGF levels were significantly correlated with the gingival index (GI) (p < 0.05). Significant correlations were identified between ESM-1 and VEGF-A and ESM-1 and TNF-α, as well as VEGF-A and TNF-α, in both the control group and following treatment (p < 0.05). Conclusions: ESM-1 and TNF-α levels decreased with non-surgical periodontal treatment in GCF. Within the limits of the study, the findings suggest that ESM-1 levels in periodontal tissues may be an indicator of periodontal disease.

## Linked entities

- **Proteins:** ESM1 (endothelial cell specific molecule 1), VEGFA (vascular endothelial growth factor A), TNF (tumor necrosis factor)
- **Diseases:** periodontitis (MONDO:0005076)

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, ESM1 (endothelial cell specific molecule 1) [NCBI Gene 11082] {aka endocan}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** periodontal disease (MESH:D010510), Periodontitis (MESH:D010518)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12108732/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12108732/full.md

---
Source: https://tomesphere.com/paper/PMC12108732